Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVALUATION OF CANCER RISK BY MEASUREMENT OF CIRCULATING MUTATIONAL BURDEN IN CARRIERS OF A GENETIC PREDISPOSITION

NCT06792721 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT06792721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06792721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVALUATION OF CANCER RISK BY MEASUREMENT OF CIRCULATING MUTATIONAL BURDEN IN CARRIERS OF A GENETIC PREDISPOSITION
Lead sponsor
Centre Francois Baclesse
Phase
Observational
Overall status
Recruiting
Start date
July 4, 2025
Completion date
December 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca mutation, breast carcinoma, cfmb, genetic predisposition to cancer, mutation burden